PURDUE EMPLOYEES WHO AUTHORED, 

EVISED 0R APPROVED THE TEXT OF PACKAGE INSERTS FOR OXYCONTIN

 

1

 

OngmaiOxyContm Package Insert Approved December 12,1995

 



 

CURRENT TITLE

CURRENT JOB DESCRIPTION

 

 

James Conover

 

Michae1 Friedman
Paul Goldenheim

ExecutivefDirector, Regulatory Affairs:
Resigned May 12, 2000

Former Purdue employee-oversaw regulatory

department 1

 

Executive Vice President, Chief Operating Officer
Executive Vice President, Worldwide 

Chief Operating Officer
Responsible for Purdue's research and development
and medical affairs

 

 

William Herlihy Associate General Counsel Legal counsel responsible-for compliance with FDA 8;
DEA law and regulations
Ellen lngber Executive Director. Project Management Leads product development teams involved In clinical

studies and product registration Issues

 

Michael Innaurato

Robert Kaiko

 

Senior Director Hospital Specialty Division

Oversees the hospital specialty sales force

 

Vice President, Clinical Research

Oversees clinical development of Purdue's products

 

Robert Reder

Vice President, Medical Affairs and Worldwide Drug Safety

 

Oversees Purdue's US medical affairs department and
worldwide drug safety and pharmacovigilence function

 

Lee Kim Storey 

Assistant Director,_Drug Safety Assurance

Evaluates safety assurance processes to assure
compliance with adverse event reporting regulations

 

Howard Udell

 

EXecutive Vice President, General Counsel

 

Chief Legal Officer

 

 

All individuals above can be reached at (203) 588-8000, with the exception of James Conover

 

 

 

 

 

 

wHo REVISED OR APPROVED THE TEXT OEPACKAGE INSERTSLEOR oxvcormig



 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



which?. 

?j _Oversees Purdue's marketing dammit

Elizabeth Connelly Manager, Regulatory Affairs Assists in ensuring that governmental requirements necessary to
obtain approval of new products and to continue production of

.. existing products are met 

Michael__if_r_i_e_dman _ExecutiveVice President, Chief Operating Of?cer Chief Operating Officer 

Paul Goldenheim Executive Vice President, Worldwide - Responsible for Purdue's research and development and medical

affairs -

William Herlihy Associate General Counsel Legal counsel responsible for compliance with FDA law

and regulations 

Ellen lngber Executive Director, Project Management Leads product development teams involved in clinical studies and

product registration issues -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ChristophEr Prue. Senior Director, U.S. RegulatoFAffairs Ensures that governmental requirements necessary to obtain?
. approval of new products and to continue production of existing
. products are met 
Pob?rt Reder Vice President, Medical Affairs and Worldwide Drug Safety Oversees Purdue's US medical affairs department and worldwide
drug safety and _pharmacovigilence function 
Patricia Richards I I Associate Medical Director Plans, designs, directs and executes assigned clinical drug
development programs for NBA submissions 
Cally-Kiddie Sr. Director, Product Management Establishes, directs, and coordinates marketing activities forall
.W 
Anthony Santopolo Vice President, US Regulatory Affairs Purdue's Senior US Regulatory Officer; responsible for ensuring
that governmental requirements necessary to obtain approval of
new products and to continue production of existing products are
met
Howard 0630"? Eiecutive Vice President, General Counsel Chief Legal Officer a

 

00530

individuals above can be reached at: (203) 588-8000

 

 

 

 

 



PURDUE EMPLOYEES WHO AUTHORED, REVISED OR APPROVED THE TEXT OF PACKAGE INSERTS FOR OXYCONTIN

 

OxyContln Patient PacRage Insert Approved January 16, 2002

 

 

NAME

Mark 

TITLE

CURRENT JOB DESCRIPTION

 

 

Vice President Marketingm

 

Elizabeth Connelly

Michael fr_ieg_i_man
Paul Goldenheim

OverEEes Purdue's marketing department

 

Manager, Regulatory Affairs

Assists in ensuring that governmental requirements necessary to
obtain approval of new products and to continUe production of
existing products are met

 

Executive Vice President Chief Operating Of?cer

Executive Vice President, Worldwide 

Chief Operating Officer
Responsible for Purdue? 3 research and development and medical

i affairs

 

William Herlihy

Associate General Counsel

Legal counsel responsible for compliance with FDA DEA law
and regulations

 

Ellen 

ChriStopher Prue

Ro?bert sale}

Vjce President, Medical Affairs and Worldwide Drug Safety

Executive Director, Project Management

Leads product development teams involved' In clinical studies and
product registration issues

 

Senior Director U. 8. Regulatory Affairs

Ensures that governmental requirements necessary to obtain
approval of new products and to continue production of existing
products are met

 

Oversees Purdue's US medical affairs department and worldwide
drug safety and pharmacovigilence function

 

Patricia Richards?

Associate Medical Director

Plans designs directs and executes assigned clinical drug
development programs for NBA submissions

 

Sally Riddle

Sr. Director, Product Management

Establishes. directs. and coordinates marketing activities for all
assigned products

 

Anthony Santopolo

Vice President, US Regulatory Affairs

Purdue's Senior US Regulatory Officer; responsible for ensuring
that governmental requirements necessary to obtain approval of
new products and to continue production of existing products are
met

 

Howard Udell

 

 

Executive Vice President, General Counsel

 

Chief Legal Officer

 

Individuals above can be reached at: (203) 588-8000

PP 00531